Acumen Pharmaceuticals, Inc. Common Stock
XNAS:ABOS
1.9
$2.05 - 15.00
$1.88 - 8.00
$1.84
$1.94
$1.88
$1.88
2.46
0.86
133565
162513.6
47758430.92
Chart
TendieTensor AI Analysis
Company
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
Fundamentals
52
-0.860000
1.222220
-0.44
100
BBG0058YJ317
BBG0058YJ326
60.57M
60.57M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own ABOS. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.